DRMA
Dermata Therapeutics
$0.84
−$0.03 (−3.89%)Oct 29, 2026
Key metrics
The numbers that frame DRMA today
- Market cap
- $3.38M
- ROIC
- -1,537.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.60
- 52wk High
- $4.66
Growth
Revenue and earnings trend for DRMA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DRMA
Is Dermata Therapeutics a good buy?
No. Dermata Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of DRMA?
Dermata Therapeutics's market capitalization is $3.38M.
What is the 52-week high for DRMA stock?
The 52-week high for Dermata Therapeutics is $4.66. The current close of $0.84 is 82% below that high.
What is the 52-week low for DRMA stock?
The 52-week low for Dermata Therapeutics is $0.60. The current close of $0.84 is 39.5% above that low.
Does DRMA stock pay dividends?
Dermata Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DRMA?
Dermata Therapeutics's Debt / Equity ratio is 0.